The EEG was continuously recorded on 43 patients who received Althesin. A basic pattern for this drug, typical of most general anaesthetic agents at a level of light surgical anaesthesia, was established. Four significant levels of change could be discriminated in the EEG following administration of incremental boluses of undiluted Althesin, reflecting deeper levels of anaesthesia. These ranged from a mild slowing of the dominant rhythms to burst-suppression activity at the deepest level reached with larger doses. The EEG demonstrated that althesin has a rapid onset and a short duration and that recovery is rapid and complete after continuous infusion.
INTRODUCTION
Although the electroencephalographic (EEG) patterns of Althesin (alphaxolone-alphadolone acetate) following a single injection have been reported previously! ,2,3, there is virtually no information about the EEG during its continuous administration in man. The purpose of this study was to record the EEG during induction with Althesin, during controlled continuous infusion and when a bolus was given as a supplement to the infusion.
METHOD
The EEG was recorded on 43 patients, 34 of whom were males, and who were undergoing elective peripheral neurosurgical procedures. Patients were excluded from the study if there was known drug sensitivity, history of liver disease or of convulsive disorders. The patients' ages ranged from 8 to 69 years. All patients were premedicated with either pethidine and atropine or papaveretum and hyoscine combinations intramuscularly. For simplicity, Althesin dosage was calculated from total body weight. The 43 patients were divided into two groups Group 1, 16 patients given *;-""1.13., 8.S., ~.F.A.R.A.C.S., Visiting Anae:-.theli",1. "Senior EEG Recordist, C.N.P.U. continuous infusions of Althesin 0.1 mllkg/hr or 0.2 mllkg/hr only; Group 2, 27 patients who received continuous infusions at these rates augmented by incremental bolus injections of the drug.
The awake EEG was recorded in 18 patients, while in the remainder recording started immediately after induction. Anaesthesia was induced with Althesin 40-60 /AI per kg body weight given over 30-60 seconds followed by an intubating dose of non-depolarizing relaxant. After intubation anaesthesia was maintained with nitrous oxide, 3 litres, and oxygen 1.5 litres, and ventilation was controlled to provide slight hypocarbia. Soon after intubation, through a separate intravenous cannula the infusion of Althesin was started. Of the 16 patients in Group 1, anaesthesia was maintained in nine throughout the operation by an infusion rate of 0.1 mllkg/hr; the rest were commenced on the same infusion but when operative time allowed, this was increased, after an average of 45 minutes, to 0.2 mllkg/hr. The average infusion time in all other patients was 48.5 mins, ranging from 10 to 102 mins.
The Group 2 patients were maintained for 15-20 mins at the initial concentration and then, provided that deep anaesthesia was not made evident by burst-suppression of the EEG, a Anaesthesia and Intensive Care, Vol. VIII, No. 2, May, 1980 bolus of undiluted Althesin was injected. After the EEG had returned to the pre-bolus baseline a further bolus was administered, In all, 61 bolus injections were given to the 27 patients in this group. Of these 27 patients, nine were maintained on 0.1 mllkg/hr infusion and 12 on 0.2 mllkg/hr infusion throughout. Six patients were started on 0.1 mllkg/hr infusion which was later increased to 0.2 mllkg/hr. In Table 1 we have added together the nine patients maintained on 0.1 mllkg/hr to the six started on 0.1 mllkg/hr, making a total of 15, and similarly the 12 patients maintained on 0.2 mllkg/hr have been added to those six patients whose infusion was increased to this concentration, totalling 18. Fourteen of the 15 patients on 0.1 mllkg/hr infusion were given a 1.0 ml bolus, 13 a 2.0 ml bolus and only one patient received a 3.0 ml bolus. Of the 18 patients on 0.2 mllkg/hr infusion 15 were given a 1.0 ml bolus, 13 a 2.0 ml bolus and a 3.0 ml bolus was administered to five patients.
Iml
The Althesin infusion was stopped usually 10-15 minutes before completion of the operation, and the EEG recording continued until the pattern of light anaesthesia emerged. Fentanyl was given to deepen anaesthesia and incremental doses of muscle relaxants administered when necessary. Anaesthesia was terminated in the usual manner with extubation after reversal of residual muscle paralysis with atropine and neostigmine. During anaesthesia, monitoring included pulse-rate, indirect bloodpressure, E.C.O. and body temperature.
RESULTS
No abnormalities were seen in any of the EEGs recorded from awake patients. The changes following the initial dose of Althesin were similar in each patient, and started between 13 and 70 seconds after the induction dose had been given. The change in EEG pattern from the waking record was abrupt and consisted initially of rhythms with a frequency of 8-12 Hz intermixed with high voltage slower activity (1.5-3 Hz). After 30-90 seconds the generally high amplitude of the tracing decreased, the slow waves became fewer in number and after 3-4 minutes had ceased altogether (Fig 1) .
The basic patterns of the EEG seen with infusion rates of 0.1 mllkg/hr or 0.2 mllkg/hr Althesin were similar. There were, however, differences in background activity which became more apparent when the concentration was increased from 0.1 mllkg/hr to 0.2 FIGURE I-EEG changes following the initial dose of Althesin. The first section is an awake recording, the second section 35 seconds after induction; the third, 20 seconds later and the final section after a further 2 minutes. These tracings are all from the right hemisphere, anterior and central electrodes.
mg/kg/hr. The most common EEG pattern for a 0.1 mllkg/hr infusion was a dominant rhythm between 7 and 12 Hz with some lower voltage fast rhythms (18-26 Hz) and a few slower 3-6 Hz background components. The dominant rhythms with the 0.2 mllkg/hr in fusions were essentially similar, with a frequency range of 6-13 Hz but with more prominent background activity at 1.5-4 Hz, although there were still low voltage fast rhythms at 18-25 Hz superimposed. In no case was there any apparent deepening of the anaesthetic level with either concentration or time. The EEG tended to be stable after the initial changes which followed the induction dose had resolved, provided the infusion rate was maintained without alteration. On two occasions there was a marked lightening reflected in the EEG by an increase in frequencies, loss of background slow waves, the appearance of low voltage spindling waveforms and an overall decrease in amplitude. These changes occurred when inadvertently less than the calculated doses were given.
In the majority of the patients in whom EEG recording was continued for more than \0 minutes after the Althesin infusion was stopped 4 there was obvious lightening of the anaesthetic level, as evidenced by the loss of Althesininduced activity. This was independent of length of time or concentration of infusion.
We recognised four significant levels of change in the EEG (Fig. 2) following administration of a bolus of Althesin. These were: 1) a slowing of the dominant frequencies by 3-4 Hz.
2) The appearance of periodic bursts of higher voltage activity, on a background of actlVlty of diminished amplitude. 3) Discontinuous EEG -slowed and further reduced in amplitude and with intermittent flat periods of 0.5-2 seconds duration. 4) Burstsuppression activity. Table 1 indicates the EEG levels reached by the patients in Group 2 following the bolus injections. Basically there was a trend for the EEG to reflect deeper levels of anaesthesia with larger increments in each concentration.
DISCUSSION
The changes in the EEG produced by various anaesthetic agents have been described 4 .;. A consistent relationship exists between the changes in the EEG and the depth of anaesthesia", equivalent to the changes seen with a decreasing cerebral metabolic rate. As the level of anaesthesia deepens the dominant rhythms in the EEG slow in frequency and then diminish in amplitude. EEG activity then becomes intermittent, with flat periods appearing. These flat periods increase in duration until only brief bursts of activity persist. This stage of burst-suppression equates with deep anaesthesia and additional anaesthesia will eventually lead to the abolition of all cerebral potentials, leaving the EEG isoelectric 7 • Broadly speaking the changes follow a fairly well-defined sequence representing alterations in total cerebral activity. The individual differences between various anaesthetic agents have perhaps been given unwarranted emphasis 8 • This study shows that the EEG changes with Althesin resemble those of other anaesthetic agents. With an increasing blood level and increasing depth of anaesthesia, the typical progression occurs in the EEG, and as expected, there were no changes specific for Althesin.
The EEG changes described were clearly attributable to Althesin rather than to the combination of Althesin, nitrous oxide and fentanyl. We have concluded this because in our patients after Althesin was stopped the EEG became significantly different and composed only of regular low voltage rhythms typical for nitrous oxide 4 ,5. Furthermore, Smith et al. 9 observed that nitrous oxide did not make EEG changes from other anaesthetic agents difficult to assess when used concomitantly. Fentanyl in clinical doses had no perceptible effect on the EEGIO. On no occasion was any epileptogenic pattern seen, even with deep anaesthesia. As reported previouslyll, no excitatory phenomena were seen either during the recording or post-operatively and in fact, the anticonvulsant effect of Althesin has already been reported l2 .
Previous reports on the EEG changes after induction with Althesin described burstsuppression patterns I ,2.3. We did not see these gross changes following induction in our study, probably because Althesin was injected more slowly and into a peripheral vein, hence limiting or reducing the peak blood level. Although in an early report by Savege et al. I burstsuppression was noted during light anaesthesia with Althesin, more recently a report from the same department considered burst-suppression occurred only with deep anaesthesia 7 • During the burst -suppression period all our patients were deeply anaesthetised by the usual clinical criteria, an observation also described by Prior et al. 13. Althesin has a short duration of action without any cumulative effect. Despite the long duration of the continuous infusion in some of our patients, within 20 minutes of cessation the EEG no longer contained Althesin-induced rhythms. In all patients clinical recovery was both rapid and complete. When an Althesin bolus was given as a supplement to a continuous infusion, not surprisingly the degree and duration of the bolus effect was dependent on the concentration of the infusion as well as the dose of the bolus. The brief effect of Althesin together with the predictable effect of a superimposed bolus provides a rapid and very flexible control of the depth of anaesthesia.
In this study we calculated the dose requirements of Althesin from total body weight. Theoretically a more reliable estimate would have been derived from the lean tissue mass. Despite our method, however, obese patients in our study did not show EEG or clinical evidence of overdosage, contrary to the observations of Crankshaw and Allt-Graham I5 • In conclusion, we found that the EEG changes of Althesin were typical of anaesthetic agents in general, and long duration of infusion did not delay recovery.
